Key result
The transsubclavian approach for TAVI using the 14-F CoreValve Evolut R device achieved 100% procedural success with no complications in 15 consecutive patients.
Why the study?
Does the transsubclavian approach for TAVI using the 14-F CoreValve Evolut R device provide safe and effective outcomes in patients undergoing TAVI?
Observational (n=15)
Does the transsubclavian approach for TAVI using the 14-F CoreValve Evolut R device provide safe and effective outcomes in patients undergoing TAVI?
The transsubclavian approach for TAVI using the 14-F CoreValve Evolut R device is a safe and feasible alternative access route, demonstrating 100% procedural success and no complications in a small case series.
TSA may be feasible for TAVI in selected patients; leaves open comparative safety and efficacy versus transfemoral in prospective trials.
AIMS: In addition to the transfemoral route, common approaches for transcatheter aortic valve implantation (TAVI) are the transapical and transaortic ones. Yet, these are associated with morbidity. The transsubclavian approach (TSA) is an alternative to minimize invasiveness. METHODS: Fifteen consecutive patients underwent TAVI via TSA using the CoreValve Evolut R. The 14F delivery system without sheath was directly introduced into the artery. RESULTS: Success was 100%; contrast volume was 99.4 ± 29.58 ml. Patients were extubated after 1.66 ± 0.89 h. Hemoglobin drop was 0.64 ± 0.28 g/dl. There were no complications. Hospital stay was 4.53 ± 1.24 days: 11 patients were discharged home, the remainder to rehabilitation. CONCLUSION: TSA is associated with limited morbidity, early patient mobilization, short hospitalization.
No takes yet. Share an insight, caveat, or question.
Anselmi et al. (2018) conducted an observational in Aortic valve disease requiring TAVI (n=15). Transsubclavian approach (TSA) for TAVI was evaluated on Procedural success. The transsubclavian approach for TAVI using the 14-F CoreValve Evolut R device achieved 100% procedural success with no complications in 15 consecutive patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: